Career Center

SoMCC Event

Title:

  Industry Insights: Roles for Scientists in the Product Commercialization Process
Date:   Thursday, January 19, 2006
Time:   5:30-7:00 PM. Program: 5:30-6:30; Refreshments: 6:30-7:00
Location:   Clark S360
Sponsor:   SoMCC & Agilent Technologies' Life Sciences and Chemical Analysis Business
Event details:  

Scientific researchers rely upon instruments, tools, and technology to solve problems and improve our understanding of scientific phenomena. The ‘product commercialization’ process for these technologies is a complex one, but simply defined it involves:

  • Recognizing and understanding opportunities for innovation
  • Designing and developing actual tools and instruments, and
  • Enabling researcheSrs to make full use of new technological capabilities

Presented by Agilent Technologies, this session provides visibility into the various ways that scientific skills and training are employed within this process, and are in fact critical to its success. The program is an excellent opportunity to meet with experienced members of Agilent’s Life Sciences and Chemical Analysis team who will lend insights on:

  • Building analytical tools & scientific applications
  • Developing the markets that will utilize these tools
  • How to structure collaborations with other thought leaders and institutions to bring the most useful products to market
Come join us for this informative discussion, hear first-hand from scientists about the specific roles they perform within a company such as Agilent, and learn more about what you can do to prepare or position yourself for these diverse scientific roles.     

Agilent Presenters:

Dr. Chris Hopkins has been with Agilent for 4 years and is a Senior Applications Scientist for their Genomics business. He works directly with potential and existing customers to enable their research with Agilent’s genomic technologies, and is specifically focused on microarray based approaches to studying DNA-protein interactions. Dr. Hopkins received his PhD in Plant Pathology from Kansas State University, and his BA in Biochemistry & Molecular Biology from UC Santa Barbara.

Dr. Leslie Leonard is an Intellectual Property Portfolio Manager for Agilent’s Proteomics business. She is responsible for assessing the technological landscape surrounding current and future products and analyzing the business impact. Dr. Leonard was an R&D Scientist at Agilent Labs for 8+ years, then worked for 2 years as an independent IP Consultant and R&D Director, and has just recently returned to Agilent as IP Manager. She received her PhD in Immunology from Johns Hopkins University.

Dr. Rudi Grimm is a Market Development Manager for Proteomics and Metabolomics at Agilent. He received his PhD in Biology and has over 100 scientific publications to his credit. His role is to work with scientists around the world to identify unmet customer needs, develop solutions for those needs, and to conduct proof of concept studies with key thought leaders. Dr. Grimm has been with Agilent for more than 10 years and is also responsible for all proteomic and metabolomics related collaborations worldwide.
Fee:   Free
Additional information and/or registration:   RSVP required. Send email to
Map:   Clark Center

Stanford Medicine Resources:

Footer Links: